141
A Single-arm, Open, Phase II Study of Chidamide Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma
Condition(s):SarcomaLast Updated:September 7, 2022Recruiting
Histone Deacetylase Inhibitors: 749 Clinical Trials, Page 15 of 75
Hide Studies Not Open or Pending
142
Resminostat (4SC-201) in Relapsed or Refractory Hodgkin’s Lymphoma
Condition(s):Hodgkin’s LymphomaLast Updated:January 16, 2014Completed
143
A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL)
Condition(s):Follicular Lymphoma; Marginal Zone Lymphoma; Mantle Cell LymphomaLast Updated:February 15, 2016Terminated
144
Multi Interventional Study Exploring HIV-1 Residual Replication: a Step Towards HIV-1 Eradication and Sterilizing Cure
Condition(s):Chronic Infection; HIVLast Updated:July 28, 2020Completed
145
Sorafenib and LBH589 in Hepatocellular Carcinoma (HCC)
Condition(s):Hepatocellular CarcinomaLast Updated:December 14, 2020Terminated
146
Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer
Condition(s):Ovarian Cancer; Fallopian Tube Cancer; Peritoneal CancerLast Updated:September 10, 2018Terminated
147
Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma
Condition(s):Cutaneous T-cell LymphomaLast Updated:December 24, 2018Terminated
148
Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer
Condition(s):Cervical CancerLast Updated:November 28, 2006Completed
149
Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat
Condition(s):Volunteers; Healthy Volunteers; Human Volunteers; Normal VolunteersLast Updated:August 16, 2018Completed
150
MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia
Condition(s):Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Chronic Myelomonocytic Leukemia; de Novo Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Refractory Anemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Ringed Sideroblasts; Refractory Cytopenia With Multilineage Dysplasia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Adult Acute Myeloid LeukemiaLast Updated:July 18, 2017Completed